New cancer injection shows promise in early trial
Disease control
Completed
This early-stage study tested an experimental drug called JCXH-211, which is injected directly into tumors. It involved 19 adults with advanced solid tumors that had not responded to standard treatments. The main goals were to check safety and find the right dose, while also watc…
Phase: PHASE1 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 19, 2026 10:27 UTC